Delanzomib

Products

Inquiry

Cat. No.: IBDI-432597

Delanzomib (CEP-18770) is a potent and orally active chymotrypsin-like activity of the proteasome inhibitor with an IC50 of 3.8 nM. Delanzomib inhibits NF-κB activity, induces cancer cell apoptotic, and has strong antiangiogenic and anti-cancer activities.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target	Proteasome \| NF-κB \| Apoptosis
Molecular Weight	413.28
Appearance	Solid
Synonyms	CEP-18770
SMILES	CC(C)C[[email protected]@H](B(O)O)NC([[email protected]@H](NC(C1=NC(C2=CC=CC=C2)=CC=C1)=O)[[email protected]](O)C)=O
Purity	≥98.0%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Powder: -20°C/3 years; 4°C/2 years In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.

! For research use only, not intended for any clinical use.